Baillie Gifford & Co. reduced its position in shares of Illumina, Inc. (NASDAQ:ILMN) by 2.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,273,316 shares of the life sciences company’s stock after selling 417,175 shares during the quarter. Illumina accounts for approximately 4.6% of Baillie Gifford & Co.’s investment portfolio, making the stock its 6th biggest holding. Baillie Gifford & Co. owned approximately 12.52% of Illumina worth $3,640,045,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of ILMN. Advisory Services Network LLC boosted its stake in shares of Illumina by 13.0% during the 2nd quarter. Advisory Services Network LLC now owns 772 shares of the life sciences company’s stock worth $134,000 after acquiring an additional 89 shares in the last quarter. Penserra Capital Management LLC boosted its stake in shares of Illumina by 13.0% during the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the life sciences company’s stock worth $153,000 after acquiring an additional 102 shares in the last quarter. Paradigm Asset Management Co. LLC boosted its stake in shares of Illumina by 5.6% during the 2nd quarter. Paradigm Asset Management Co. LLC now owns 950 shares of the life sciences company’s stock worth $165,000 after acquiring an additional 50 shares in the last quarter. NN Investment Partners Holdings N.V. boosted its stake in shares of Illumina by 11.3% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock worth $171,000 after acquiring an additional 100 shares in the last quarter. Finally, Elefante Mark B boosted its stake in shares of Illumina by 3.7% during the 2nd quarter. Elefante Mark B now owns 1,253 shares of the life sciences company’s stock worth $218,000 after acquiring an additional 45 shares in the last quarter. 93.04% of the stock is currently owned by institutional investors and hedge funds.

ILMN has been the topic of several recent analyst reports. Leerink Swann reissued an “outperform” rating and set a $225.00 target price (up from $207.00) on shares of Illumina in a research note on Tuesday, September 12th. Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $226.00 price target (up from $202.00) on shares of Illumina in a research note on Monday, October 9th. Morgan Stanley reaffirmed an “underweight” rating and issued a $122.00 price target (up from $115.00) on shares of Illumina in a research note on Monday, July 10th. Vetr raised shares of Illumina from a “hold” rating to a “buy” rating and set a $217.50 price target on the stock in a research note on Tuesday, September 19th. Finally, BidaskClub lowered shares of Illumina from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $200.88.

In related news, CAO Michel Bouchard sold 616 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $200.00, for a total transaction of $123,200.00. Following the transaction, the chief accounting officer now owns 15,161 shares of the company’s stock, valued at $3,032,200. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Charles Dadswell sold 1,609 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $197.00, for a total transaction of $316,973.00. Following the transaction, the senior vice president now directly owns 9,037 shares in the company, valued at approximately $1,780,289. The disclosure for this sale can be found here. Insiders have sold 171,635 shares of company stock worth $34,944,643 in the last three months. Insiders own 1.60% of the company’s stock.

Shares of Illumina, Inc. (NASDAQ ILMN) traded up 0.95% during mid-day trading on Wednesday, hitting $207.14. 190,853 shares of the stock were exchanged. The stock has a market cap of $30.24 billion, a PE ratio of 41.56 and a beta of 0.76. Illumina, Inc. has a one year low of $119.37 and a one year high of $214.50. The company has a 50-day moving average of $205.60 and a 200 day moving average of $188.90.

Illumina (NASDAQ:ILMN) last announced its quarterly earnings data on Tuesday, October 24th. The life sciences company reported $1.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $0.12. The business had revenue of $714.00 million for the quarter, compared to the consensus estimate of $692.77 million. Illumina had a net margin of 30.34% and a return on equity of 19.42%. The company’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.97 earnings per share. On average, equities analysts predict that Illumina, Inc. will post $3.65 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Baillie Gifford & Co. Sells 417,175 Shares of Illumina, Inc. (ILMN)” was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://theolympiareport.com/2017/11/01/baillie-gifford-co-sells-417175-shares-of-illumina-inc-ilmn.html.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.